Zurueck zur Suche

Reporte zur Charge U78278AA

Verknuepft ueber VAERS_ID mit VAERSDATA, Vax und Symptoms

1Reporte angezeigt
0Todesfaelle
0Hospitalisiert
0Lebensbedrohlich
0Bleibende Schaeden
IL 1

VAERS 2684864

UNKNOWN MANUFACTURER · MENINGOCOCCAL (NO BRAND NAME) · Charge U78278AA

gering
Staat
IL
Alter
20,0
Geschlecht
F
Eingang
21.09.2023
Impfdatum
15.09.2023
Beginn
15.09.2023
Tage bis Beginn
0,0
Dosis
UNK
Route/Site
OT / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Medication error No adverse event Wrong product administered

Symptomtext

medical assistant inadvertently administered a dose of menquadfi, when they were supposed to receive the mmr vaccine with no reported adverse event; Initial information received on 15-Sep-2023 regarding an unsolicited valid non-serious case received from other health professional. This case involves a 20-years-old female patient who was inadvertently administered with a dose of meningococcal A-C-Y-W135 (T conj) vaccine [Menquadfi], when they were supposed to receive the measles vaccine, mumps vaccine, rubella vaccine [MMR] with no reported adverse event. The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided. On 15-Sep-2023, the patient inadvertently received 0.5 mL dose of suspect meningococcal A-C-Y-W135 (T conj) vaccine, Solution for injection (frequency: once) (batch number: U78278AA; expiry date: 30-Sep-2025) via unknown route in unknown administration site when they were supposed to receive the measles vaccine, mumps vaccine, rubella vaccine vaccine (formulation batch number and expiry unknown) for immunization with no reported adverse event (wrong product administered). Action taken: not applicable. At time of reporting, the outcome was Unknown. This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in the Directive 2001/83/EC and Module VI of the Good Pharmacovigilance Practices. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Medication error
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-